retatrutide triple agonist phase 2 nejm 2023 obesity results Original Article: Triple–Hormone-Receptor for — A Trial https://t.co/jNL1GNnHPT #ADA23 Retatrutide: Phase 3 Results (Up

Life Sciences 1 min read Regulator steps up oversight of GLP-1 drug distribution chain This aims to ensure strict adherence to approval conditions and labeling, preventing diversion and unauthorized sales

10.1371/journal.pone.0211193 247

This includes magnesium, calcium, vitamin C, and B vitamins

Semaglutide mimics the hormone GLP-1, which helps regulate appetite and glucose

In Clinical Follow this topic Bookmark Record learning outcomes Learning objectives After reading this feature you should: Be familiar with the mode of action of GLP-1 receptor agonists Understand the NICE guidance on their use in weight management Be aware of the possible side-effects of these treatments and how to counsel patients to minimise them

This was not a reported side effect in Wegovy clinical trials